Electra Therapeutics: First-in-class SIRP-targeted therapy for sHLH with ELA026—Excedr covers this major biotech funding round. Explore data and pipeline.
Reduce downtime and extend equipment life with proven lab maintenance strategies—plus how leasing simplifies upkeep.
Explore tools and strategies to improve lab equipment tracking, minimize downtime, and streamline operations.
When equipment fails, should you fix it, replace it, or lease a new one? This guide helps you decide fast.
Learn how to build a smarter lab equipment budget that supports growth, flexibility, and long-term savings.
Avoid costly lab buildout delays by learning the top causes—and how leasing can help speed up your setup.
Discover the true cost of owning lab equipment and explore ways to cut expenses without compromising quality.
NewLimit raises $45M to advance epigenetic reprogramming therapies targeting cellular aging—Excedr covers this major biotech funding round.
Pelage Pharmaceuticals raises $120M Series B for PP405 stem cell therapy in hair loss—Excedr covers this major biotech funding round.
Peptilogics raises $78M to develop AI-designed peptides for joint infections—Excedr covers this major biotech funding round.
